Medical/Pharmaceuticals

Zai Lab Announces Financial Results for Six Months Ended June 30, 2020 and Corporate Updates

SHANGHAI and SAN FRANCISCO, Aug. 13, 2020 /PRNewswire/ -- Zai Lab Limited (NASDAQ: ZLAB), an innovative commercial-stage biopharmaceutical company, today announced financial results for the six months ended June 30, 2020 and corporate updates. "This year we have continued to build Zai Lab's lead...

2020-08-13 22:38 6972

AGC Biologics Enters into Partnership as a CDMO with Ono Pharmaceuticals to Manufacture Biopharmaceuticals at Clinical Development Stage

SEATTLE, Aug. 13, 2020 /PRNewswire/ -- AGC Biologics, a global biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced it is partnering with Ono Pharmaceutical Co., Ltd. (ONO) to manufacture new, innovative biopharmaceuticals at the clinical development stage. ONO...

2020-08-13 21:00 4966

ANTI-PD-1/CTLA-4 Bi-specific Antibody (AK104) of Akeso Granted FDA Fast Track Designation for Recurrent and Metastatic Cervical Cancer

LOS ANGELES, Aug. 13, 2020 /PRNewswire/ -- Akeso, Inc (9926.HK) - a biopharmaceutical company dedicated to the research, development, manufacturing and commercialization of new innovative antibody drugs that are affordable to patients worldwide - today announced that the U.S. Food and Drug Admini...

2020-08-13 20:07 5481

Ajinomoto Bio-Pharma Services Expands Small Molecule Manufacturing Capabilities at its India Facility

WETTEREN, Belgium, Aug. 13, 2020 /PRNewswire/ -- Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, is pleased to announce a major expansion of small molecule manufacturing capabilities with the addition of a ...

2020-08-13 20:06 3327

WuXi AppTec Achieved Strong Growth in First-Half of 2020 with China Sites Resuming Full Operations

WuXi AppTec Second-Quarter 2020 Results Revenue Up 29.4% YoY to RMB4,044 Million Net Profit Attributable to Owners of the Company Up 111.0% YoY to RMB1,414 Million Diluted EPS Up 110.3% YoY to RMB0.61 Adjusted Non-IFRS Net Profit Attributable to Owners of the Company Up 43.1% YoY toRMB942 Million...

2020-08-13 16:49 5117

CanSinoBIO's Successful Listing on STAR Market Makes it the Initial Dual Listing Vaccine Company

SHANGHAI, Aug. 13, 2020 /PRNewswire/ -- CanSino Biologics Inc. ("CanSinoBIO") (SHSE: 688185, HKEX:06185) announced today that it has successfully listed on the Sci-Tech Innovation Board (STAR Market) of the Shanghai Stock Exchange, making it the first "A+ H" dual listing vaccine company. CanSinoB...

2020-08-13 10:00 10869

Australian Therapeutic Goods Administration Approves the First Phase I Trial of ATG-017 for the Treatment of Patients with Advanced Solid Tumors and Hematological Malignancies

SHANGHAI and MELBOURNE, Australia, Aug. 13, 2020 /PRNewswire/ -- Antengene Corporation, a leading innovative hematology and oncology-focused biopharmaceutical company, announced today the authorization of the first-in-human trial of ATG-017 (ERASER trial) by the Australian Therapeutic Goods Admi...

2020-08-13 06:00 2567

Health Canada provides COVID-19 Interim Order approval for Bactiguard's endotracheal tubes

STOCKHOLM, Aug. 13, 2020 /PRNewswire/ -- Health Canada has approved Bactiguard's endotracheal tubes for infection prevention through an Interim Order. The approval is driven by COVID-19, as Bactiguard's endotracheal tubes can reduce the risk of secondary infections for critically ill patients. "...

2020-08-13 04:33 3013

Innovent and Eli Lilly Announce Acceptance of a Supplemental New Drug Application of TYVYT® (Sintilimab Injection) in Combination with Gemcitabine and Platinum as First-Line Therapy in Squamous Non-Small Cell Lung Cancer in China

SUZHOU, China, Aug. 12, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune and other major diseases, today joi...

2020-08-12 16:40 8017

United Imaging, Debuting at AHRA as a Gold Sponsor, Announces FDA Clearance of Its Latest Deep Learning Reconstruction Technology, uAI HYPER DLR

HOUSTON, Aug. 11, 2020 /PRNewswire/ -- United Imaging, a global leader in advanced medical imaging and radiotherapy equipment, has received FDA clearance for uAI HYPER DLR (Deep Learning Reconstruction), an advanced image processing function intended to reduce the noise of fluorodeoxyglucose (FDG...

2020-08-12 00:00 1834

CPHI to Hold Second Quarter 2020 Earnings Conference Call On Friday August 14, 2020 at 8:30 a.m. ET

HAIKOU CITY, China, Aug. 11, 2020 /PRNewswire/ -- China Pharmaceutical Holdings Limited (NYSE American: CPHI) ("China Pharma" or "Company"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based inChina, today announced that it plans to hold its 2n...

2020-08-11 22:10 5990

PharmaSources Launches the Export-Driven Event CPhI & P-MEC China E-Trade Season

SHANGHAI, Aug. 11, 2020 /PRNewswire/ -- PharmaSources, an international B2B trade portal for the pharmaceutical verticals, is launching the virtual event CPhI & P-MEC China E-Trade Season from August toDecember 2020. Consisting of the three sessions "Top API Exporters & Products", "Popular Natura...

2020-08-11 18:35 3561

TCM Lianhua Qingwen Capsule approved for registration in the Philippines

SHIJIAZHUANG, China, Aug. 11, 2020 /PRNewswire/ -- Yiling Pharmaceutical Co., Ltd.announced on Monday that it has received a drug registration certificate issued by the Food and Drug Administration ofthe Philippines, indicating Lianhua Qingwen Capsule has been registered in accordance with the st...

2020-08-11 17:31 4240

OssDsign AB signs business partner agreement with Muranaka Medical Instruments Co., Ltd., in Japan

STOCKHOLM, Aug. 11, 2020 /PRNewswire/ -- OssDsign AB (Publ) ("OssDsign") today announced that the company has signed a business partner agreement with Muranaka Medical Instruments Co., Ltd., ("Muranaka"), a pre-eminent medical product distributor inJapan. Muranaka will represent OssDsign commerci...

2020-08-11 15:50 2674

Trendlines Medical Shanghai Opens its Doors

- Trendlines Medical Shanghai partners with Chinese medical companies, governmental programs, and entrepreneurs to develop novel medical technologies for the Chinese and global markets. SHANGHAI and  MISGAV, Israel, Aug. 11, 2020 /PRNewswire/ -- The Trendlines Group Ltd.

2020-08-11 07:01 4249

AGC Biologics Expands Partnership with Novavax

Manufacturing of Novavax' Matrix-M™Adjuvant for Novel COVID-19 Vaccine Expands toSeattle SEATTLE, Aug. 11, 2020 /PRNewswire/ -- AGC Biologics, a global biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced it has expanded its partnership withNovavax, Inc. (NASDA...

2020-08-11 04:20 6858

New Thermo Scientific Selectris Filters Push Cryo-EM Boundaries with Atomic Resolution

Zero-loss energy filters enable life scientists to view protein structures in unprecedented detail HILLSBORO, Oregon, Aug. 11, 2020 /PRNewswire/ -- Thermo Fisher Scientific, the world leader in serving science, today introduced two breakthrough imaging filters, the Thermo Scientific Selectris Im...

2020-08-11 04:17 3818

PHC Holdings Corporation and Ascensia Diabetes Care Announce Financing Agreement and Exclusive Global Commercial Agreement With Senseonics

TOKYO and BASEL, Switzerland, Aug. 11, 2020 /PRNewswire/ -- PHC Holdings Corporation and Ascensia Diabetes Care, a PHC Group company, today announced a strategic partnership with Senseonics Holdings, Inc., a medical technology company focused on the development and commercialization of long-term,...

2020-08-11 04:02 3605

Global Fund Launches Search for Inspector General

GENEVA, Aug. 11, 2020 /PRNewswire/ -- The Global Fund to Fight AIDS, Tuberculosis and Malaria has launched a search for its next Inspector General. A seven-member nomination committee will help the Board of the Global Fund select the next Inspector General. The Board welcomes all candidates with ...

2020-08-11 01:05 4021

New Study Proves Asclepius Meditec's Hydrogen Oxygen Generator Helps Improve COVID-19 Disease Severity and Dyspnea

SHANGHAI, Aug. 10, 2020 /PRNewswire/ -- An innovative, environmentally friendly treatment with no side effects has been made available to COVID-19 patients, involving the electrolysis of H2O to produce a mixture of hydrogen and oxygen for human inhalation. The results of the research as a treatme...

2020-08-10 21:00 2803
1 ... 542543544545546547548 ... 608